In vitro screening of EPS-producing Streptococcus thermophilus strains for their probiotic potential from Dahi

Dahi is a very common and traditional fermented dairy product in Pakistan and its neighboring countries, it represents a rich source for the isolation of many new strains of lactic acid bacteria (LAB). The major objective of this study was to evaluate the probiotic potential of novel exopolysaccharide (EPS)-producing strains of S. thermophilus isolated from Dahi, sold in the local markets of Rawalpindi and Islamabad, Pakistan. In this study, 32 isolates of S. thermophilus were initially isolated from Dahi and out of these, 10 identified strains were further screened for their EPS-producing ability. Maximum EPS production was estimated for RIY strain (133.0 +/- 0.06), followed by RIH4 strain (103.83 +/- 0.76) and RIRT2 strain (95.77 +/- 0.22), respectively. Thereafter, in vitro studies revealed that these newly identified EPS-producing strains of S. thermophitus fulfilled the basic requirements for probiotic functions; including resistance to harsh conditions of GIT, good cell surface hydrophobicity, auto-aggregation, and co-aggregation, especially against L. monocytogenes. Finally, the safety assessment displayed that these strains were also sensitive to clinical antibiotics, including vancomycin. Thus, these selected EPS strains of S. thermophilus act as potential candidates for biostabilizers in the preparation of consumer-friendly fermented probiotic milk products.

Automated summary

This study evaluated the probiotic potential of S. thermophilus strains isolated from Dahi sold in the local markets of Rawalpindi and Islamabad, Pakistan. The study found that these strains could produce exopolysaccharide (EPS), exhibited probiotic functions, inhibited L. monocytogenes, and were sensitive to clinical antibiotics. Therefore, these strains have potential as candidates for biostabilizers in consumer-friendly fermented probiotic milk products.